Companion Animal Diagnostics Market by Technology (Clinical Biochemistry, Urinalysis, Immunodiagnostic, Hematology, Molecular Diagnostics), Application (Clinical Pathology, Bacteriology, Parasitology), Animal (Dog, Cat), End User - Global Forecast to 2024

コンパニオンアニマル診断の世界市場予測(~2024年)

◆タイトル:Companion Animal Diagnostics Market by Technology (Clinical Biochemistry, Urinalysis, Immunodiagnostic, Hematology, Molecular Diagnostics), Application (Clinical Pathology, Bacteriology, Parasitology), Animal (Dog, Cat), End User - Global Forecast to 2024
◆商品コード:MD-7053
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年4月1日
◆ページ数:279
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥615,850見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥724,850見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥888,350見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、コンパニオンアニマル診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別(臨床生化学、尿検査、免疫診断、血液学、分子診断)分析、用途別( 臨床病理学、細菌学、寄生虫学)分析、動物別(犬、猫)分析、エンドユーザー別分析、コンパニオンアニマル診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The companion animal diagnostics market is projected to reach USD 2.7 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 9.8%. The rising companion animal population, increasing demand for pet insurance, and the growth in the number of veterinary practitioners in developed economies are the major factors that are driving the growth of the global companion animal diagnostics market. The growing demand for rapid tests and portable instruments for point-of-care services is expected to offer potential growth opportunities for market players in the coming years. However, the increasing pet care costs are expected to restrain market growth to a certain extent.
Companion animal diagnostics market for dogs to grow at the highest CAGR during the forecast period
Based on animal type, the companion animal diagnostics market is segmented into dogs, cats, horses, and other companion animals. The dogs segment is expected to grow at the highest CAGR during the forecast period majorly due to the growing dog ownership, increasing prevalence of infectious and zoonotic diseases, growing occurrence of skin allergies in dogs, rising healthcare expenditure for dogs, and the growing penetration of pet health insurance.

Point-of-care/in-house testing segment to witness the highest growth during the forecast period
Based on end user, the companion animal diagnostics market is segmented into reference laboratories, veterinary hospitals & clinics, point-of-care/in-house testing, and research institutes and universities. The point-of-care/in-house testing segment is estimated to grow at the highest CAGR during the forecast period owing to the advantages of POC/in-house testing, including ease of use and accurate, real-time results.

Asia Pacific market to witness the highest growth during the forecast period
The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period majorly due to the growing adoption of companion animals, increasing awareness about pet healthcare and zoonotic diseases, and the growing number of veterinary hospitals and clinics in several APAC countries.

Breakdown of primary participants from the supply side:
• By Company Type – Tier 1–35%, Tier 2–40%, and Tier 3–25%
• By Designation – C Level–25%, Director Level–30%, and Others–45%
• By Region – North America–30%, Europe–35%, Asia Pacific–15%, Latin America- 10%, and Middle East and Africa–10%

Some of the major players operating in the companion animal diagnostics market are IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), Thermo Fisher Scientific, Inc. (US), Virbac (France), Heska Corporation (US), Neogen Corporation (US), bioMérieux SA (France), IDvet (France), INDICAL Bioscience GmbH (Germany) [QIAGEN N.V. (Netherlands)], and Randox Laboratories Ltd. (UK).
Research Coverage:
This report analyzes the companion animal diagnostics market and aims at estimating the size and future growth potential of this market based on various segments, namely, technology, application, animal type, end user, and region. The report also includes a product portfolio matrix of the companion animal diagnostic products available in the market. The competitive leadership mapping provided in this report helps analyze the position of market players as visionary leaders, innovators, dynamic players, and emerging players. A comprehensive competitive analysis of key players in this market, along with their company profiles, product offerings, recent developments, and key growth strategies, has also been provided in this report.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their position in the market:

• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global companion animal diagnostics market. The report analyzes this market by technology, application, animal type, end user, and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global companion animal diagnostics market.
• Market Development: Comprehensive information on the lucrative emerging markets by technology, application, animal type, end user, and region.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global companion animal diagnostics market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global companion animal diagnostics market.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.3 SCOPE OF THE STUDY 28
1.3.1 MARKETS COVERED 28
1.3.2 YEARS CONSIDERED FOR THE STUDY 29
1.4 CURRENCY 29
1.5 LIMITATIONS 30
1.6 STAKEHOLDERS 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
2.1.1 SECONDARY SOURCES 32
2.1.1.1 Key data from secondary sources 33
2.1.2 PRIMARY SOURCES 34
2.1.2.1 Primary sources 34
2.1.2.2 Key data from primary sources 35
2.1.2.3 Key industry insights 36
2.2 MARKET SIZE ESTIMATION 38
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 40
2.4 MARKET SHARE ESTIMATION 41
2.5 ASSUMPTIONS FOR THE STUDY 41
3 EXECUTIVE SUMMARY 42
4 PREMIUM INSIGHTS 46
4.1 COMPANION ANIMAL DIAGNOSTICS: MARKET OVERVIEW 46
4.2 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, 2018 47
4.3 COMPANION ANIMAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 48
4.4 COMPANION ANIMAL DIAGNOSTICS MARKET: GEOGRAPHIC MIX 49
4.5 COMPANION ANIMAL DIAGNOSTICS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES/REGIONS 50
5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 51
5.3 KEY MARKET DRIVERS 52
5.3.1 GROWTH IN THE COMPANION ANIMAL POPULATION 52
5.3.2 RISING DEMAND FOR PET INSURANCE 53
5.3.3 GROWTH IN THE NUMBER OF VETERINARY PRACTITIONERS IN DEVELOPED ECONOMIES 54
5.4 KEY MARKET RESTRAINTS 55
5.4.1 INCREASING PET CARE COSTS 55
5.5 KEY MARKET OPPORTUNITIES 55
5.5.1 GROWING DEMAND FOR RAPID TESTS & PORTABLE INSTRUMENTS FOR POINT-OF-CARE (POC) DIAGNOSTIC SERVICES 55
5.6 KEY CHALLENGES 56
5.6.1 LACK OF ANIMAL HEALTHCARE AWARENESS IN EMERGING MARKETS 56
5.6.2 SHORTAGE OF VETERINARIANS IN EMERGING MARKETS 56
6 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY 57
6.1 INTRODUCTION 58
6.2 CLINICAL BIOCHEMISTRY 60
6.2.1 CLINICAL CHEMISTRY ANALYSIS 61
6.2.1.1 Reagent clips and cartridges 63
6.2.1.1.1 Reagent clips and cartridges accounted for the largest share of the clinical chemistry analysis market 63
6.2.1.2 Analyzers 64
6.2.1.2.1 Clinical chemistry analyzers have wide applications in veterinary hospitals, reference laboratories, small clinics, and research institutes 64
6.2.2 GLUCOSE MONITORING 65
6.2.2.1 Blood glucose strips 67
6.2.2.1.1 Blood glucose strips segment accounted for the largest share of the glucose monitoring market in 2018 67
6.2.2.2 Glucose monitors 68
6.2.2.2.1 The use of glucose monitors helps in making diagnostic and therapeutic decisions in a relatively inexpensive manner 68
6.2.2.3 Urine glucose strips 69
6.2.2.3.1 Urine glucose strips are used to measure glucose and ketone concentrations in urine 69
6.2.3 BLOOD GAS ELECTROLYTE ANALYSIS 70
6.2.3.1 Reagent clips and cartridges 72
6.2.3.1.1 Reagent clips and cartridges segment commanded the largest share of the blood gas electrolyte analysis market in 2018 72
6.2.3.2 Analyzers 73
6.2.3.2.1 Blood gas electrolyte analyzers are used to determine blood pH and the amount of oxygen and carbon dioxide in the blood 73
6.3 IMMUNODIAGNOSTICS 74
6.3.1 LATERAL FLOW ASSAYS 76
6.3.1.1 Rapid tests 78
6.3.1.1.1 Rising prevalence of infectious diseases to drive the adoption of lateral flow rapid tests 78
6.3.1.2 Strip readers 79
6.3.1.2.1 Lateral flow strip readers are not frequently used by veterinary practitioners 79
6.3.2 ELISA TESTS 80
6.3.2.1 ELISA tests segment to register the highest growth rate during the forecast period 80
6.3.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS 81
6.3.3.1 Growing number of allergy cases in pets to drive market growth 81
6.3.4 IMMUNOASSAY ANALYZERS 82
6.3.4.1 Large number of samples can be loaded into immunoassay analyzers to determine the results of immunoassay tests 82
6.3.5 OTHER IMMUNODIAGNOSTIC PRODUCTS 83
6.4 HEMATOLOGY 84
6.4.1 CARTRIDGES 85
6.4.1.1 Hematology cartridges are used to measure the hematocrit and hemoglobin level in animal blood samples 85
6.4.2 ANALYZERS 86
6.4.2.1 Hematology analyzers are used to measure blood cell counts and the coagulation time of blood 86
6.5 URINALYSIS 87
6.5.1 URINALYSIS CLIPS AND CARTRIDGES/PANELS 89
6.5.1.1 Urinalysis clips and cartridges/panels are used to measure multiple electrolytes and metabolites for the detection of kidney diseases, urinary tract infections, and diabetes 89
6.5.2 URINE ANALYZERS 90
6.5.2.1 Technological innovations to drive market growth 90
6.5.3 URINE TEST STRIPS 91
6.5.3.1 Urine test strips are used for the qualitative evaluation of urine parameters 91
6.6 MOLECULAR DIAGNOSTICS 92
6.6.1 POLYMERASE CHAIN REACTION (PCR) TESTS 94
6.6.1.1 PCR testing identifies a pathogen based on the presence of the pathogen’s DNA or RNA in the patient specimen, before antibody can be detected, making it a useful diagnostic tool for early disease detection in sick animals 94
6.6.2 MICROARRAYS 95
6.6.2.1 Increased speed and accuracy of screening and confirmation are driving the use of microarrays in the diagnosis of various therapeutic conditions in companion animals 95
6.6.3 OTHER MOLECULAR DIAGNOSTIC PRODUCTS 96
6.7 OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES 97

7 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION 98
7.1 INTRODUCTION 99
7.2 CLINICAL PATHOLOGY 100
7.2.1 CLINICAL PATHOLOGY DOMINATES THE COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION 100
7.3 BACTERIOLOGY 101
7.3.1 RISING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE THE MARKET FOR BACTERIOLOGY 101
7.4 VIROLOGY 102
7.4.1 RISING NUMBER OF VIRAL OUTBREAKS ARE CONTRIBUTING TO MARKET GROWTH IN THIS SEGMENT 102
7.5 PARASITOLOGY 103
7.5.1 INCREASING PREVALENCE OF PARASITIC DISEASES TO SUPPORT THE GROWTH OF THIS APPLICATION SEGMENT 103
7.6 OTHER APPLICATIONS 104
8 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE 105
8.1 INTRODUCTION 106
8.2 DOGS 108
8.2.1 INCREASE IN THE DOG POPULATION AND THEIR OWNERSHIP RATE—KEY GROWTH DRIVER FOR THIS SEGMENT 108
8.3 CATS 109
8.3.1 GROWING RESEARCH ON THE HEALTHCARE AND WELLBEING OF CATS TO SUPPORT THE GROWTH OF THIS SEGMENT 109
8.4 HORSES 110
8.4.1 GROWING AWARENESS ABOUT EQUINE HEALTH TO DRIVE MARKET GROWTH 110
8.5 OTHER COMPANION ANIMALS 112
9 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER 114
9.1 INTRODUCTION 115
9.2 REFERENCE LABORATORIES 115
9.2.1 REFERENCE LABS RECEIVE LARGE NUMBERS OF SAMPLES FROM VETERINARY PRACTICES 115
9.3 VETERINARY HOSPITALS & CLINICS 116
9.3.1 HOSPITALS & CLINICS ARE THE FIRST POINT OF CONTACT FOR PET OWNERS 116
9.4 POINT-OF-CARE/IN-HOUSE TESTING 118
9.4.1 NEED TO IMPROVE CARE AND REDUCE COSTS HAS DRIVEN THE ADOPTION OF POC DIAGNOSTICS 118
9.5 RESEARCH INSTITUTES & UNIVERSITIES 119
9.5.1 INDUSTRY-ACADEMIA COLLABORATION HAS GROWN IN RECENT YEARS 119

10 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION 121
10.1 INTRODUCTION 122
10.2 NORTH AMERICA 123
10.2.1 US 130
10.2.1.1 US dominates the companion animal diagnostics market in North America 130
10.2.2 CANADA 136
10.2.2.1 Awareness of pet health has risen in Canada 136
10.3 EUROPE 141
10.3.1 GERMANY 148
10.3.1.1 Germany is the largest market for companion animal diagnostics in Europe 148
10.3.2 UK 154
10.3.2.1 Stable increase in pet ownership and preventive measures against animal diseases promoted by regulatory authorities to drive the UK market 154
10.3.3 FRANCE 159
10.3.3.1 Technological expertise and innovations attract market players to compete in the companion animal diagnostics market in France 159
10.3.4 ITALY 165
10.3.4.1 Increased pet adoption, along with better availability of pet products through large-scale outlets, is supporting market growth in Italy 165
10.3.5 SPAIN 170
10.3.5.1 Rising animal health expenditure and the growing number of veterinary facilities to drive the growth of this market 170
10.3.6 REST OF EUROPE 174
10.4 ASIA PACIFIC 179
10.4.1 CHINA 186
10.4.1.1 China dominates the Asia Pacific companion animal diagnostics market 186
10.4.2 JAPAN 191
10.4.2.1 Rising demand for imported pet breeds is expected to drive the companion animal diagnostics market in Japan 191
10.4.3 INDIA 196
10.4.3.1 India is an untapped market with huge growth potential 196
10.4.4 REST OF APAC 201
10.5 LATIN AMERICA 205
10.5.1 BRAZIL 211
10.5.1.1 Brazil has the third-largest pet population country in the world 211
10.5.2 MEXICO 216
10.5.2.1 Mexico is the second-largest pet care market in Latin America 216
10.5.3 REST OF LATIN AMERICA 220

10.6 MIDDLE EAST AND AFRICA 225
10.6.1 RELUCTANCE TO SPEND ON PET HEALTH HAS SLOWED PACE OF MARKET GROWTH 225
11 COMPETITIVE LANDSCAPE 231
11.1 INTRODUCTION 231
11.2 GROWTH STRATEGY MATRIX 233
11.3 MARKET SHARE ANALYSIS (2018) 233
11.4 COMPETITIVE LEADERSHIP MAPPING 234
11.4.1 VISIONARY LEADERS 235
11.4.2 INNOVATORS 235
11.4.3 DYNAMIC DIFFERENTIATORS 235
11.4.4 EMERGING COMPANIES 235
11.5 COMPETITIVE SITUATION AND TRENDS 237
11.5.1 PRODUCT LAUNCHES 237
11.5.2 ACQUISITIONS 238
11.5.3 PARTNERSHIPS 238
11.5.4 EXPANSIONS 239
12 COMPANY PROFILES 240
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
12.1 IDEXX LABORATORIES, INC. 240
12.2 ZOETIS INC. 243
12.3 THERMO FISHER SCIENTIFIC INC. 247
12.4 VIRBAC 250
12.5 HESKA CORPORATION 254
12.6 NEOGEN CORPORATION 257
12.7 BIOMÉRIEUX SA 260
12.8 INDICAL BIOSCIENCE GMBH (QIAGEN N.V.) 262
12.9 IDVET 264
12.10 RANDOX LABORATORIES, LTD. 265
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
13 APPENDIX 267
13.1 INSIGHTS OF INDUSTRY EXPERTS 267
13.2 DISCUSSION GUIDE 268
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 275
13.4 AVAILABLE CUSTOMIZATIONS 277
13.5 RELATED REPORTS 277
13.6 AUTHOR DETAILS 278

LIST OF TABLES

TABLE 1 STANDARD CURRENCY CONVERSION RATES 29
TABLE 2 NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012–2016) (USD MILLION) 54
TABLE 3 DEVELOPED ECONOMIES: NUMBER OF VETERINARY PROFESSIONALS
(2012–2017) 54
TABLE 4 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY 56
TABLE 5 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 59
TABLE 6 COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 59
TABLE 7 CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017–2024 (USD MILLION) 60
TABLE 8 CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 61
TABLE 9 KEY CLINICAL CHEMISTRY ANALYSIS PRODUCTS AVAILABLE IN THE MARKET 62
TABLE 10 CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 62
TABLE 11 CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 63
TABLE 12 CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 64
TABLE 13 CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 65
TABLE 14 KEY GLUCOSE MONITORING PRODUCTS AVAILABLE IN THE MARKET 66
TABLE 15 GLUCOSE MONITORING MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 66
TABLE 16 GLUCOSE MONITORING MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 67
TABLE 17 BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 68
TABLE 18 GLUCOSE MONITORS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 69
TABLE 19 URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 70
TABLE 20 BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 71
TABLE 21 BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 71
TABLE 22 BLOOD GAS ELECTROLYTE REAGENT CLIPS AND CARTRIDGES MARKET,
BY COUNTRY, 2017–2024 (USD MILLION) 72
TABLE 23 BLOOD GAS ELECTROLYTE ANALYZERS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 73
TABLE 24 KEY COMPANION ANIMAL IMMUNODIAGNOSTIC PRODUCTS AVAILABLE
IN THE MARKET 74
TABLE 25 IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 75
TABLE 26 IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 76
TABLE 27 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 77
TABLE 28 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 77
TABLE 29 LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 78
TABLE 30 LATERAL FLOW STRIP READERS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 79
TABLE 31 ELISA TESTS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 80
TABLE 32 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS, BY COUNTRY,
2017–2024 (USD MILLION) 81
TABLE 33 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 82
TABLE 34 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 83
TABLE 35 KEY HEMATOLOGY PRODUCTS AVAILABLE IN THE MARKET 84
TABLE 36 HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 84
TABLE 37 HEMATOLOGY MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 85
TABLE 38 HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 86
TABLE 39 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 87
TABLE 40 KEY URINALYSIS PRODUCTS AVAILABLE IN THE MARKET 88
TABLE 41 URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 88
TABLE 42 URINALYSIS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 89
TABLE 43 URINALYSIS CLIPS AND CARTRIDGES/PANELS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 90
TABLE 44 URINE ANALYZERS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 91
TABLE 45 URINE TEST STRIPS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 92
TABLE 46 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 93
TABLE 47 MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 93
TABLE 48 PCR TESTS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 94
TABLE 49 MICROARRAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 95
TABLE 50 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 96
TABLE 51 OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 97
TABLE 52 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017-2024 (USD MILLION) 99
TABLE 53 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CLINICAL PATHOLOGY,
BY COUNTRY, 2017-2024 (USD MILLION) 100
TABLE 54 COMPANION ANIMAL DIAGNOSTICS MARKET FOR BACTERIOLOGY,
BY COUNTRY, 2017-2024 (USD MILLION) 101
TABLE 55 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VIROLOGY, BY COUNTRY,
2017-2024 (USD MILLION) 102
TABLE 56 COMPANION ANIMAL DIAGNOSTICS MARKET FOR PARASITOLOGY, BY COUNTRY, 2017-2024 (USD MILLION) 103
TABLE 57 COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2017-2024 (USD MILLION) 104
TABLE 58 COMPANION ANIMAL POPULATION (2014–2017) (MILLION) 107
TABLE 59 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD MILLION) 107
TABLE 60 COMPANION ANIMAL DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY,
2017–2024 (USD MILLION) 108
TABLE 61 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CATS, BY COUNTRY,
2017–2024 (USD MILLION) 110
TABLE 62 HORSE POPULATION, BY REGION, 2014–2017 (MILLION) 111
TABLE 63 COMPANION ANIMAL DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY,
2017–2024 (USD MILLION) 112
TABLE 64 OTHER COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 113
TABLE 65 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 115
TABLE 66 COMPANION ANIMAL DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, 2017–2024 (USD MILLION) 116
TABLE 67 VETERINARY VISIT EXPENSES FOR CATS AND DOGS IN THE US 117
TABLE 68 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS AND CLINICS, 2017–2024 (USD MILLION) 117
TABLE 69 COMPANION ANIMAL DIAGNOSTICS MARKET FOR POINT-OF-CARE/IN-HOUSE TESTING, 2017–2024 (USD MILLION) 118
TABLE 70 COMPANION ANIMAL DIAGNOSTICS MARKET FOR RESEARCH INSTITUTES AND UNIVERSITIES, 2017–2024 (USD MILLION) 120
TABLE 71 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION,
2017–2024 (USD MILLION) 122
TABLE 72 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 125
TABLE 73 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 125
TABLE 74 NORTH AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2017–2024 (USD MILLION) 125
TABLE 75 NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 126
TABLE 76 NORTH AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 126
TABLE 77 NORTH AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 126
TABLE 78 NORTH AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 127
TABLE 79 NORTH AMERICA: HEMATOLOGY MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 127
TABLE 80 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 127
TABLE 81 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 128
TABLE 82 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017–2024 (USD MILLION) 128
TABLE 83 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 129
TABLE 84 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017–2024 (USD MILLION) 129
TABLE 85 US: PRIVATE CLINICAL PRACTICES, BY ANIMAL TYPE, 2012 VS. 2017 131
TABLE 86 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 131
TABLE 87 US: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017–2024 (USD MILLION) 132
TABLE 88 US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 132
TABLE 89 US: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 132
TABLE 90 US: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 133
TABLE 91 US: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 133
TABLE 92 US: HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 133
TABLE 93 US: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 134
TABLE 94 US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 134
TABLE 95 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD MILLION) 134
TABLE 96 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 135
TABLE 97 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 135
TABLE 98 COMPANION ANIMAL POPULATION IN CANADA, 2014 VS. 2016 (MILLION) 136
TABLE 99 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 137
TABLE 100 CANADA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017–2024 (USD MILLION) 137
TABLE 101 CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 137
TABLE 102 CANADA: GLUCOSE MONITORING MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 138
TABLE 103 CANADA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 138
TABLE 104 CANADA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 138
TABLE 105 CANADA: HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 139
TABLE 106 CANADA: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 139
TABLE 107 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 139
TABLE 108 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD MILLION) 140
TABLE 109 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 140
TABLE 110 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 141
TABLE 111 EUROPE: NUMBER OF VETERINARIANS, 2012–2016 143
TABLE 112 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 143
TABLE 113 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 144
TABLE 114 EUROPE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017–2024 (USD MILLION) 144
TABLE 115 EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 144
TABLE 116 EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 145
TABLE 117 EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 145
TABLE 118 EUROPE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 145
TABLE 119 EUROPE: HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 146
TABLE 120 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 146
TABLE 121 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 146
TABLE 122 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD MILLION) 147
TABLE 123 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 147
TABLE 124 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 148
TABLE 125 GERMANY: COMPANION ANIMAL POPULATION, 2010–2017 (MILLION) 148
TABLE 126 GERMANY: NUMBER OF VETERINARIANS, 2014 VS. 2016 149
TABLE 127 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 149
TABLE 128 GERMANY: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2017–2024 (USD MILLION) 150
TABLE 129 GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 150
TABLE 130 GERMANY: GLUCOSE MONITORING MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 150
TABLE 131 GERMANY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 151
TABLE 132 GERMANY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 151
TABLE 133 GERMANY: HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 151
TABLE 134 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 152
TABLE 135 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 152
TABLE 136 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD MILLION) 152
TABLE 137 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 153
TABLE 138 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 153
TABLE 139 UK: COMPANION ANIMAL POPULATION (2010–2014) (MILLION) 154
TABLE 140 UK: NUMBER OF VETERINARIANS, 2014 VS. 2016 155
TABLE 141 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 155
TABLE 142 UK: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017–2024 (USD MILLION) 155
TABLE 143 UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 156
TABLE 144 UK: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 156
TABLE 145 UK: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 156
TABLE 146 UK: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 157
TABLE 147 UK: HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 157
TABLE 148 UK: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 157
TABLE 149 UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 158
TABLE 150 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD MILLION) 158
TABLE 151 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 158
TABLE 152 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 159
TABLE 153 FRANCE: COMPANION ANIMAL POPULATION, 2010–2017 (MILLION) 160
TABLE 154 FRANCE: NUMBER OF VETERINARIANS, 2014 VS. 2016 160
TABLE 155 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 160
TABLE 156 FRANCE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017–2024 (USD MILLION) 161
TABLE 157 FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 161
TABLE 158 FRANCE: GLUCOSE MONITORING MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 161
TABLE 159 FRANCE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 162
TABLE 160 FRANCE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 162
TABLE 161 FRANCE: HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 162
TABLE 162 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 163
TABLE 163 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 163
TABLE 164 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD MILLION) 163
TABLE 165 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 164
TABLE 166 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 164
TABLE 167 ITALY: NUMBER OF VETERINARIANS, 2012 VS. 2016 165
TABLE 168 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 165
TABLE 169 ITALY: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017–2024 (USD MILLION) 166
TABLE 170 ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 166
TABLE 171 ITALY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 166
TABLE 172 ITALY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 167
TABLE 173 ITALY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 167
TABLE 174 ITALY: HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 167
TABLE 175 ITALY: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 168
TABLE 176 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 168
TABLE 177 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD MILLION) 168
TABLE 178 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 169
TABLE 179 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 169
TABLE 180 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 170
TABLE 181 SPAIN: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017–2024 (USD MILLION) 171
TABLE 182 SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 171
TABLE 183 SPAIN: GLUCOSE MONITORING MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 171
TABLE 184 SPAIN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 172
TABLE 185 SPAIN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 172
TABLE 186 SPAIN: HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 172
TABLE 187 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 173
TABLE 188 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 173
TABLE 189 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD MILLION) 173
TABLE 190 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 174
TABLE 191 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 174
TABLE 192 COMPANION ANIMAL OWNERSHIP IN THE REST OF EUROPE, 2017 (MILLION) 175
TABLE 193 ROE: NUMBER OF VETERINARIANS AND PARAVETERINARIANS (2010 VS. 2016) 175
TABLE 194 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 175
TABLE 195 ROE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017–2024 (USD MILLION) 176
TABLE 196 ROE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 176
TABLE 197 ROE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 176
TABLE 198 ROE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 177
TABLE 199 ROE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 177
TABLE 200 ROE: HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 177
TABLE 201 ROE: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 178
TABLE 202 ROE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 178
TABLE 203 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD MILLION) 178
TABLE 204 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 179
TABLE 205 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 179
TABLE 206 APAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 181
TABLE 207 APAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 181
TABLE 208 APAC: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017–2024 (USD MILLION) 182
TABLE 209 APAC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 182
TABLE 210 APAC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 182
TABLE 211 APAC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 183
TABLE 212 APAC: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 183
TABLE 213 APAC: HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 183
TABLE 214 APAC: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 184
TABLE 215 APAC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 184
TABLE 216 APAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD MILLION) 184
TABLE 217 APAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 185
TABLE 218 APAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 185
TABLE 219 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 186
TABLE 220 CHINA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017–2024 (USD MILLION) 187
TABLE 221 CHINA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 187
TABLE 222 CHINA: GLUCOSE MONITORING MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 187
TABLE 223 CHINA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 188
TABLE 224 CHINA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 188
TABLE 225 CHINA: HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 188
TABLE 226 CHINA: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 189
TABLE 227 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 189
TABLE 228 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD 189
TABLE 229 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 190
TABLE 230 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 190
TABLE 231 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 191
TABLE 232 JAPAN: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017–2024 (USD MILLION) 192
TABLE 233 JAPAN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 192
TABLE 234 JAPAN: GLUCOSE MONITORING MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 192
TABLE 235 JAPAN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 193
TABLE 236 JAPAN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 193
TABLE 237 JAPAN: HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 193
TABLE 238 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 194
TABLE 239 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 194
TABLE 240 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD MILLION) 194
TABLE 241 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 195
TABLE 242 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 195
TABLE 243 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 196
TABLE 244 INDIA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017–2024 (USD MILLION) 197
TABLE 245 INDIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 197
TABLE 246 INDIA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 197
TABLE 247 INDIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 198
TABLE 248 INDIA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 198
TABLE 249 INDIA: HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 198
TABLE 250 INDIA: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 199
TABLE 251 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 199
TABLE 252 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD MILLION) 199
TABLE 253 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 200
TABLE 254 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 200
TABLE 255 ROAPAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 201
TABLE 256 ROAPAC: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017–2024 (USD MILLION) 201
TABLE 257 ROAPAC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 202
TABLE 258 ROAPAC: GLUCOSE MONITORING MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 202
TABLE 259 ROAPAC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 202
TABLE 260 ROAPAC: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 203
TABLE 261 ROAPAC: HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 203
TABLE 262 ROAPAC: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 203
TABLE 263 ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 204
TABLE 264 ROAPAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD MILLION) 204
TABLE 265 ROAPAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 204
TABLE 266 ROAPAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 205
TABLE 267 LATIN AMERICA: NUMBER OF VETERINARIANS AND PARAVETERINARIANS
(2010 VS. 2016) 205
TABLE 268 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 206
TABLE 269 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 206
TABLE 270 LATIN AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2017–2024 (USD MILLION) 206
TABLE 271 LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 207
TABLE 272 LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 207
TABLE 273 LATIN AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 207
TABLE 274 LATIN AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 208
TABLE 275 LATIN AMERICA: HEMATOLOGY MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 208
TABLE 276 LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 208
TABLE 277 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 209
TABLE 278 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017–2024 (USD MILLION) 209
TABLE 279 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 210
TABLE 280 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017–2024 (USD MILLION) 210
TABLE 281 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 211
TABLE 282 BRAZIL: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017–2024 (USD MILLION) 211
TABLE 283 BRAZIL: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 212
TABLE 284 BRAZIL: GLUCOSE MONITORING MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 212
TABLE 285 BRAZIL: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 212
TABLE 286 BRAZIL: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 213
TABLE 287 BRAZIL: HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 213
TABLE 288 BRAZIL: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 213
TABLE 289 BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 214
TABLE 290 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD MILLION) 214
TABLE 291 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 215
TABLE 292 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 215
TABLE 293 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 216
TABLE 294 MEXICO: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017–2024 (USD MILLION) 216
TABLE 295 MEXICO: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 217
TABLE 296 MEXICO: GLUCOSE MONITORING MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 217
TABLE 297 MEXICO: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 217
TABLE 298 MEXICO: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 218
TABLE 299 MEXICO: HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 218
TABLE 300 MEXICO: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 218
TABLE 301 MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 219
TABLE 302 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD MILLION) 219
TABLE 303 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 219
TABLE 304 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 220
TABLE 305 ROLATAM: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 221
TABLE 306 ROLATAM: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2017–2024 (USD MILLION) 221
TABLE 307 ROLATAM: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 221
TABLE 308 ROLATAM: GLUCOSE MONITORING MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 222
TABLE 309 ROLATAM: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 222
TABLE 310 ROLATAM: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 222
TABLE 311 ROLATAM: HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 223
TABLE 312 ROLATAM: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 223
TABLE 313 ROLATAM: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 223
TABLE 314 ROLATAM: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD MILLION) 224
TABLE 315 ROLATAM: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 224
TABLE 316 ROLATAM: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 225
TABLE 317 MIDDLE EAST: NUMBER OF VETERINARIANS AND PARAVETERINARIANS
(2010 VS. 2016) 225
TABLE 318 AFRICA: NUMBER OF VETERINARIANS AND PARAVETERINARIANS (2010 VS. 2016) 226
TABLE 319 MEA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 226
TABLE 320 MEA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017–2024 (USD MILLION) 227
TABLE 321 MEA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 227
TABLE 322 MEA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 227
TABLE 323 MEA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 228
TABLE 324 MEA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 228
TABLE 325 MEA: HEMATOLOGY MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 228
TABLE 326 MEA: URINALYSIS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 229
TABLE 327 MEA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 229
TABLE 328 MEA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2017–2024 (USD MILLION) 229
TABLE 329 MEA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 230
TABLE 330 MEA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2017–2024 (USD MILLION) 230
TABLE 331 PRODUCT LAUNCHES (JANUARY 2015–FEBRUARY 2019) 237
TABLE 332 ACQUISITIONS ( JANUARY 2015- FEBRUARY 2019) 238
TABLE 333 PARTNERSHIPS (JANUARY 2015- FEBRUARY 2019) 238
TABLE 334 EXPANSIONS (JANUARY 2015- FEBRUARY 2019) 239



LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 31
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 37
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 37
FIGURE 4 BOTTOM-UP APPROACH 39
FIGURE 5 TOP-DOWN APPROACH 39
FIGURE 6 DATA TRIANGULATION METHODOLOGY 40
FIGURE 7 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019 VS. 2024 (USD MILLION) 42
FIGURE 8 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2019 VS. 2024 (USD MILLION) 43
FIGURE 9 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019 VS. 2024 (USD MILLION) 43
FIGURE 10 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2019 VS. 2024 (USD MILLION) 44
FIGURE 11 GEOGRAPHIC SNAPSHOT: COMPANION ANIMAL DIAGNOSTICS MARKET 45
FIGURE 12 GROWING COMPANION ANIMAL POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 46
FIGURE 13 CHINA HOLDS THE LARGEST SHARE OF THE APAC COMPANION ANIMAL DIAGNOSTICS MARKET IN 2018 47
FIGURE 14 CHINA AND INDIA TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 48
FIGURE 15 NORTH AMERICA WILL CONTINUE TO DOMINATE THE COMPANION ANIMAL DIAGNOSTICS MARKET BY 2024 49
FIGURE 16 DEVELOPING MARKETS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 50
FIGURE 17 DEVELOPED COUNTRIES: PET POPULATION & PET OWNERSHIP 52
FIGURE 18 US: PET INDUSTRY EXPENDITURE 53
FIGURE 19 COMPANION ANIMAL DIAGNOSTICS MARKET SEGMENTATION, BY TECHNOLOGY 58
FIGURE 20 CLINICAL PATHOLOGY WILL CONTINUE TO DOMINATE THE COMPANION ANIMAL DIAGNOSTICS MARKET DURING THE FORECAST PERIOD 99
FIGURE 21 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE 106
FIGURE 22 GEOGRAPHIC SNAPSHOT (2018): US ACCOUNTED FOR THE LARGEST SHARE OF THE COMPANION ANIMAL DIAGNOSTICS MARKET 123
FIGURE 23 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT 124
FIGURE 24 US: PET OWNERSHIP INDICATORS, 2017 130
FIGURE 25 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT 142
FIGURE 26 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT 180
FIGURE 27 KEY DEVELOPMENTS IN THE COMPANION ANIMAL DIAGNOSTICS MARKET BETWEEN JANUARY 2015 AND FEBRUARY 2019 232
FIGURE 28 COMPANION ANIMAL DIAGNOSTICS MARKET SHARE ANALYSIS,
BY KEY PLAYER, 2018 233
FIGURE 29 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2018) 240
FIGURE 30 ZOETIS INC.: COMPANY SNAPSHOT (2018) 243
FIGURE 31 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2018) 247
FIGURE 32 VIRBAC: COMPANY SNAPSHOT (2017) 250
FIGURE 33 HESKA CORPORATION: COMPANY SNAPSHOT(2018) 254
FIGURE 34 NEOGEN CORPORATION: COMPANY SNAPSHOT (2018) 257
FIGURE 35 BIOMERIEUX SA: COMPANY SNAPSHOT (2018) 260
FIGURE 36 QIAGEN N.V.: COMPANY SNAPSHOT (2018) 262




★調査レポート[コンパニオンアニマル診断の世界市場予測(~2024年)] ( Companion Animal Diagnostics Market by Technology (Clinical Biochemistry, Urinalysis, Immunodiagnostic, Hematology, Molecular Diagnostics), Application (Clinical Pathology, Bacteriology, Parasitology), Animal (Dog, Cat), End User - Global Forecast to 2024 / MD-7053) 販売に関する免責事項
[コンパニオンアニマル診断の世界市場予測(~2024年)] ( Companion Animal Diagnostics Market by Technology (Clinical Biochemistry, Urinalysis, Immunodiagnostic, Hematology, Molecular Diagnostics), Application (Clinical Pathology, Bacteriology, Parasitology), Animal (Dog, Cat), End User - Global Forecast to 2024 / MD-7053) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆